相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Left Atrial Volume and the Benefit of Cardiac Resynchronization Therapy in the MADIT-CRT Trial
Rafael Kuperstein et al.
CIRCULATION-HEART FAILURE (2014)
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
Hicham Skali et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Are Serial BNP Measurements Useful in Heart Failure Management? Serial Natriuretic Peptide Measurements Are Useful in Heart Failure Management
James L. Januzzi et al.
CIRCULATION (2013)
Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study
Diana Bonderman et al.
CIRCULATION (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
Left Ventricular Dysfunction With Pulmonary Hypertension Part 2: Prognosis, Noninvasive Evaluation, Treatment, and Future Research
Andreas P. Kalogeropoulos et al.
CIRCULATION-HEART FAILURE (2013)
Baseline Characteristics of Patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
Sanjiv J. Shah et al.
CIRCULATION-HEART FAILURE (2013)
Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression
Matthias Oelze et al.
EUROPEAN HEART JOURNAL (2013)
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN HEART JOURNAL (2013)
Soluble guanylate cyclase: a potential therapeutic target for heart failure
Mihai Gheorghiade et al.
HEART FAILURE REVIEWS (2013)
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
Frank Edelmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Dirk J. van Veldhuisen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
Loek van Heerebeek et al.
CIRCULATION (2012)
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction
Tomohito Ohtani et al.
EUROPEAN HEART JOURNAL (2012)
Why do drugs for acute heart failure fail?
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study
John G. F. Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes
Mihai Gheorghiade et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Endothelial Dysfunction A Pathophysiologic Factor in Heart Failure With Preserved Ejection Fraction
Carolyn S. P. Lam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
sGCα1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling
Sharon M. Cawley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Hydralazine and Isosorbide Dinitrate in Heart Failure Historical Perspective, Mechanisms, and Future Directions
Robert T. Cole et al.
CIRCULATION (2011)
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Michael R. Zile et al.
CIRCULATION (2011)
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Johannes-Peter Stasch et al.
CIRCULATION (2011)
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
Mihai Gheorghiade et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Biomonitoring and Biomarker-Guided Therapy The Next Step in Heart Failure and Biomarker Research
Alan Maisel
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Early Deaths in Patients With Heart Failure Discharged From the Emergency Department A Population-Based Analysis
Douglas S. Lee et al.
CIRCULATION-HEART FAILURE (2010)
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Emily J. Tsai et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction
Jasmine Grewal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice
Emmanuel S. Buys et al.
CARDIOVASCULAR RESEARCH (2008)
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.
Barry M. Massie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
How to diagnose diastolic heart failure:: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
Walter J. Paulus et al.
EUROPEAN HEART JOURNAL (2007)
Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial
Marvin A. Konstam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Explaining the phenomenon of nitrate tolerance
T Münzel et al.
CIRCULATION RESEARCH (2005)
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome Study with Tolvaptan (EVEREST)
M Gheorghiade et al.
JOURNAL OF CARDIAC FAILURE (2005)
Primary results of the rapid emergency department heart failure outpatient trial (REDHOT)
A Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction - Results from the breathing not properly multinational study
AS Maisel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
G Boerrigter et al.
CIRCULATION (2003)
Cardiac endothelial-myocardial signaling: Its role in cardiac growth, contractile performance, and rhythmicity
DL Brutsaert
PHYSIOLOGICAL REVIEWS (2003)
分享论文
